Biocure Operations Report

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF) (the "Company" or "Biocure") is pleased to provide a shareholders' update on its operations.

Biocure Announces: Breakthrough Pre-Clinical Trial Results for CAR-T Cells Treatment of Acute Leukemia

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF) (the "Company" or "Biocure") announces today the successful results of the Pre-Clinical Trial of safety...

BioCure Announces the Appointment of a New Director

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the “Company” or “Biocure”) is pleased to announce that effective of...